Dimethoxycurcumin 및 curcumin 합성유도체가 RAW264.7 대식세포의 nitric oxide 생성에 미치는 효과 = Effects of Dimethoxycurcumin, a Synthetic Curcumin Analogue,on Nitric Oxide Production in RAW264.7 Macrophage

국문 초록 (Abstract)

목 적 : 급성 및 만성 염증 질환은 iNOS에 의해서 생성된 과량의 NO와 관련이 있다. 따라서 이러한 질병 치료를 목적으로 NO 생성 억제물질 또는 iNOS 발현 차단물질을 개발할 가치가 있다. 본 연구는 대사 안정성을 개선시킨 dimethoxycurcumin (DiMC)이 활성화된 대식세포에서 NO 생성 및 iNOS 발현을 제어할 수 있는지 조사하였다. 방 법 : RAW264.7 세포를 DiMC (양쪽 방향성 고리에 각각 2개의 methoxy group을 가짐), curcumin (양쪽 방향성 고리에 각각 1개의 methoxy group을 가짐), bis-demethoxycurcumin (양쪽 방향성 고리에 methoxy group이 없음; BDMC) 및 tetrahydrocurcumin (양쪽 방향성 고리에 각각 1개의 methoxy group을 가지고 있지만 중앙 7개 탄소 사슬에 이중결합이 없음; THC)로 각각 전처리한 후에 LPS로 자극하였다. 이들 전처리 물질의 효과를 비교하기 위하여, NO 생성, iNOS 발현, NF-kB p65 인산화 및 p65 DNA-binding 활성을 조사하였다. 결 과 : DiMC, curcumin 및 BDMC는 NO 생성, iNOS 발현 및 NF-kB 활성을 억제하였으며, 그 세기에 있어서 DiMC가 가장 크게 관찰되었고 그 다음 curcumin 그리고 BDMC 순으로 관찰되었다. THC는 어떠한 활성도 보이지 못했다. 결 론 : DiMC는 NO 생성 억제, iNOS 발현 차단 및 NF-kB 비활성을 유도할 수 있음을 알 수 있었다. 이러한 효과는 연속된 이중결합 및 methoxy group의 증가와 관련이 있는 것으로 판단된다.

참고문헌 (Reference)

1 Murakami A, "Zerumbone, a Southeast Asian ginger sesquiterpene, markedly suppresses free radical generation, proinflammatory protein production, and cancer cell proliferation accompanied by apoptosis: the alpha, beta‐unsaturated carbonyl group is a prerequisite" 23 : 795-802, 2002

2 Seo WG, "Synergistic cooperation between water‐soluble chitosan oligomers and interferon‐gamma for induction of nitric oxide synthesis and tumoricidal activity in murine peritoneal macrophages" 159 : 189-195, 2000

3 Tonnesen H, "Studies on curcumin and curcuminoids XV. Catalytic effect of demethoxy and bisdemethoxycurcumin on the peroxidation of linoleic acid by 15‐lipoxygenase" 51 : 179-181, 1989

4 Chen CC, "Signal transduction pathways of inflammatory gene expressions and therapeutic implications" 12 : 3497-3508, 2006

5 Hyun-Ock Pae,Gil-Saeng Jeong, "Roles of heme oxygenase-1 in curcumin-induced growthinhibition in rat smooth muscle cells" 생화학분자생물학회 39 (39): 267-277, 2007

6 Sandur SK, "Role of pro‐oxidants and antioxidants in the anti‐inflammatory and apoptotic effects of curcumin (diferuloylmethane)" 43 : 568-580, 2007

7 Sanchez‐Gomez FJ, "Protein thiol modification by 15‐deoxy‐Delta12,14‐prostaglandin J2 addition in mesangial cells: role in the inhibition of pro‐inflammatory genes" 66 : 1349-1358, 2004

8 Salerno L, "Progress in the development of selective nitric oxide synthase (NOS) inhibitors" 8 : 177-200, 2002

9 Viatour P, "Phosphorylation of NF‐kappaB and IkappaB proteins: implications in cancer and inflammation" 30 : 43-52, 2005

10 Cheng AL, "Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high‐risk or pre‐malignant lesions" 21 : 2895-2900, 2001

11 Choi BM, "Nitric oxide as a pro‐apoptotic as well as anti‐apoptotic modulator" 35 : 116-126, 2002

12 Chung HT, "Nitric oxide as a bioregulator of apoptosis" 282 : 1075-1079, 2001

13 Nam NH, "Naturally occurring NF‐kappaB inhibitors" 6 : 945-951, 2006

14 Tamvakopoulos C, "Metabolism and anticancer activity of the curcumin analogue, dimethoxycurcumin" 13 : 1269-1277, 2007

15 Chan MM, "In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti‐inflammatory properties" 55 : 1955-1962, 1998

16 Sandur SK, "Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti‐inflammatory and anti‐proliferative responses through a ROS‐independent mechanism" 28 : 1765-1773, 2007

17 Pae HO, "Curcumin induces pro‐apoptotic endoplasmic reticulum stress in human leukemia HL‐60 cells" 353 : 1040-1045, 2007

18 Chen WF, "Curcumin and its analogues as potent inhibitors of low density lipoprotein oxidation: H‐atom abstraction from the phenolic groups and possible involvement of the 4‐hydroxy‐3‐methoxyphenyl groups" 40 : 526-535, 2006

19 Pan MH, "Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down‐regulation of IkappaB kinase and NFkappaB activation in macrophages" 60 : 1665-1676, 2000

20 정길생, "Comparative effects of curcuminoids on endothelial heme oxygenase-1 expression: ortho-methoxy groups are essential to enhance heme oxygenase activity and protection" 생화학분자생물학회 38 (38): 393-400, 2006

21 Plummer SM, "Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents" 10 : 1295-1299, 2001

22 Ireson C, "Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester‐induced prostaglandin E2 production" 61 : 1058-1064, 2001

23 Oh GS, "Capsazepine, a vanilloid receptor antagonist, inhibits the expression of inducible nitric oxide synthase gene in lipopolysaccharide‐stimulated RAW264.7 macrophages through the inactivation of nuclear transcription factor‐B" 1 : 777-784, 2001

24 Rossi A, "Anti‐inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase" 403 : 103-108, 2000

25 Aggarwal BB, "Anticancer potential of curcumin: preclinical and clinical studies" 23 : 363-398, 2003